1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7078)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22470)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10530)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (298)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22470)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma
    Journal Article

    Kaley, T. J.; Panageas, K. S.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Abrey, L. E.; Holland, E. C.; Lassman, A. B.
    Journal of Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm
    Journal Article

    Lacambra, M. D.; Weinreb, I.; Demicco, E. G.; Chow, C.; Sung, Y. S.; Swanson, D.; To, K. F.; Wong, K. C.; Antonescu, C. R.; Dickson, B. C.
    Genes Chromosomes and Cancer (2019)

    Fulltext@MSK | Save
  • Standard antithymocyte globulin dosing results in poorer outcomes in overexposed patients after ex vivo CD34(+) selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Bhatt, V.; Hilden, P.; Smith, M.; Thoren, K.; Cho, C.; Shah, G. L.; Maloy, M. A.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Evolution at the edge of expanding populations
    Journal Article

    Deforet, M.; Carmona-Fontaine, C.; Korolev, K. S.; Xavier, J. B.
    American Naturalist (2019)

    Fulltext@MSK | Save
  • CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma
    Journal Article

    Attiyeh, M. A.; Chakraborty, J.; McIntyre, C. A.; Kappagantula, R.; Chou, Y.; Askan, G.; Seier, K.; Gonen, M.; Basturk, O.; Balachandran, V. P.; more...
    Abdominal Radiology (2019)

    Fulltext@MSK | Save
  • Genetic targeting of ERK1/ERK2 kinases impairs the fitness of the myeloproliferative neoplasm clone
    Meeting Abstract

    Stivala, S.; Brkic, S.; Dirnhofer, S.; Passweg, J. R.; Tsakiris, D. A.; Neel, B. G.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Radimerski, T.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Dual JAK2 and ERK1/2 kinase inhibition as a potent corrective approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Jungius, S.; Santopolo, A.; Passweg, J. R.; Tsakiris, D.; Radimerski, T.; Munck, J.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Modeling and targeting KIAA1549-BRAE driven CNS tumors
    Meeting Abstract

    Kannan, R.; Cook, P.; Yao, Z.; Lee, J.; Mastroleo, C.; Ogrodowski, P.; Rosen, N.; Benezra, R.; Ventura, A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save